FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q92622163> ?p ?o ?g. }

• Q92622163 description "2020 nî lūn-bûn" @default.
• Q92622163 description "2020年の論文" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年学术文章" @default.
• Q92622163 description "2020年學術文章" @default.
• Q92622163 description "2020年學術文章" @default.
• Q92622163 description "2020年學術文章" @default.
• Q92622163 description "2020年學術文章" @default.
• Q92622163 description "2020年學術文章" @default.
• Q92622163 description "2020년 논문" @default.
• Q92622163 description "article científic" @default.
• Q92622163 description "article scientific" @default.
• Q92622163 description "article scientifique" @default.
• Q92622163 description "articol științific" @default.
• Q92622163 description "articolo scientifico" @default.
• Q92622163 description "artigo científico" @default.
• Q92622163 description "artigo científico" @default.
• Q92622163 description "artigo científico" @default.
• Q92622163 description "artikel ilmiah" @default.
• Q92622163 description "artikull shkencor" @default.
• Q92622163 description "artikulong pang-agham" @default.
• Q92622163 description "artykuł naukowy" @default.
• Q92622163 description "artículo científico publicado en 2020" @default.
• Q92622163 description "artículu científicu" @default.
• Q92622163 description "bilimsel makale" @default.
• Q92622163 description "bài báo khoa học" @default.
• Q92622163 description "naučni članak" @default.
• Q92622163 description "scienca artikolo" @default.
• Q92622163 description "scientific article published on 02 January 2020" @default.
• Q92622163 description "scientific article published on 2 January 2020" @default.
• Q92622163 description "scientific article published on 2 January 2020" @default.
• Q92622163 description "teaduslik artikkel" @default.
• Q92622163 description "tieteellinen artikkeli" @default.
• Q92622163 description "tudományos cikk" @default.
• Q92622163 description "vedecký článok" @default.
• Q92622163 description "vetenskaplig artikel" @default.
• Q92622163 description "videnskabelig artikel udgivet 2. januar 2020" @default.
• Q92622163 description "vitenskapelig artikkel" @default.
• Q92622163 description "vitskapeleg artikkel" @default.
• Q92622163 description "vědecký článek" @default.
• Q92622163 description "wetenschappelijk artikel" @default.
• Q92622163 description "wissenschaftlicher Artikel" @default.
• Q92622163 description "επιστημονικό άρθρο" @default.
• Q92622163 description "мақолаи илмӣ" @default.
• Q92622163 description "наукова стаття, опублікована в січні 2020" @default.
• Q92622163 description "научна статия" @default.
• Q92622163 description "научная статья" @default.
• Q92622163 description "научни чланак" @default.
• Q92622163 description "научни чланак" @default.
• Q92622163 description "מאמר מדעי" @default.
• Q92622163 description "مقالة علمية نشرت في 2 يناير 2020" @default.
• Q92622163 description "২ জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q92622163 description "บทความทางวิทยาศาสตร์" @default.
• Q92622163 description "სამეცნიერო სტატია" @default.
• Q92622163 name "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 name "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 type Item @default.
• Q92622163 label "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 label "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 prefLabel "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 prefLabel "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)" @default.
• Q92622163 P1433 Q92622163-CB2080E7-24F2-4B0A-936A-3158C9DE489B @default.
• Q92622163 P1476 Q92622163-D11D319B-BDEA-41FC-BBCB-6C3AECB4DE6B @default.
• Q92622163 P2093 Q92622163-02858950-ABE8-413E-98A5-ED38176C5E6F @default.
• Q92622163 P2093 Q92622163-0681C5A8-32BE-4105-A3C2-3E58ECF173D8 @default.
• Q92622163 P2093 Q92622163-0A1353AB-0CE1-4356-9F65-5A5BA076E80B @default.
• Q92622163 P2093 Q92622163-0AF9E163-E5A3-4328-B0A2-7DA91BBA91E7 @default.
• Q92622163 P2093 Q92622163-1A493035-AB0F-4B7B-81A5-01EFA5A488A7 @default.
• Q92622163 P2093 Q92622163-1B4B7646-D0F9-4D6B-B779-934D5A37BB5D @default.
• Q92622163 P2093 Q92622163-28C0297E-6487-4227-886B-EE2D5C4C0A28 @default.
• Q92622163 P2093 Q92622163-5A502A07-5418-446E-92E0-A2EC0968B542 @default.
• Q92622163 P2093 Q92622163-789AC16D-B54D-4060-AD65-5E26EBD4BDEA @default.
• Q92622163 P2093 Q92622163-C69605BC-100D-4B72-872B-1BD807AC3FC5 @default.
• Q92622163 P2093 Q92622163-D9046CDC-7836-47EC-8731-CE029B74DED4 @default.
• Q92622163 P2093 Q92622163-E81FA3E8-240D-4538-903E-4D9EDF5EE7DC @default.
• Q92622163 P2093 Q92622163-FAE9A9B5-7CD3-4158-8675-0570867F8937 @default.
• Q92622163 P2860 Q92622163-00A78D82-C9F1-477F-91DA-C2C4E9C421B7 @default.
• Q92622163 P2860 Q92622163-07BB3C3A-4648-48EE-A36E-37BF285196F6 @default.
• Q92622163 P2860 Q92622163-08F29384-C187-4CBB-ADB9-77DA7F2492B9 @default.
• Q92622163 P2860 Q92622163-2205E5D8-9432-4E04-B6B6-92C0CA5137EA @default.
• Q92622163 P2860 Q92622163-27070B2D-3D2F-452B-8E7E-AC833B3A80FE @default.
• Q92622163 P2860 Q92622163-29B2023C-12CD-4B52-9E72-22FB685CACE3 @default.
• Q92622163 P2860 Q92622163-35D898CB-95FC-49D4-8EE0-AF05D73292AB @default.
• Q92622163 P2860 Q92622163-41D5779C-FBC3-4C24-8C57-FDB4687E9331 @default.
• Q92622163 P2860 Q92622163-45608879-4662-45C4-BE82-32CB9FE72424 @default.
• Q92622163 P2860 Q92622163-64D9F44E-A10E-43A3-A8E1-4EBA1691F735 @default.
• Q92622163 P2860 Q92622163-6F078030-FD68-47CA-967D-DF4B28746959 @default.
• Q92622163 P2860 Q92622163-7C78BA44-6A66-4BAD-BEB9-C21E9E8E9CA0 @default.
• Q92622163 P2860 Q92622163-9883A300-A1EA-4663-A5B4-0C6095BACE5E @default.
• Q92622163 P2860 Q92622163-ADE80FAF-FA33-4663-908D-E9D6E959FC98 @default.
• Q92622163 P2860 Q92622163-AEC060BB-8D64-4960-B3E5-D3E48C92AEE2 @default.
• Q92622163 P2860 Q92622163-C2FA11D6-FB87-4223-871E-20DA47DF5ABE @default.
• Q92622163 P2860 Q92622163-C45C5E7C-0F4F-49AC-9C79-D43181D8B712 @default.
• Q92622163 P2860 Q92622163-EDB5CBCA-79E9-44CF-978F-2B3BC3B28088 @default.
• Q92622163 P2860 Q92622163-F7EB69F0-4D46-491B-8172-17D155853504 @default.
• Q92622163 P2860 Q92622163-FCA07BA6-9980-41DA-A96B-3883DE6FD40D @default.

• next